Dalfampridine 10 mg Suppliers & Bulk Manufacturers
Available Forms: Extended-Release tablets (XR)
Available Strengths: 10 mg
Reference Brands: Ampyra(US)
Category: Multiple sclerosis
Dalfampridine ER is a potassium channel blocker that enhances nerve signal conduction in damaged nerves. It improves walking speed and mobility in multiple sclerosis patients. Benefits include better gait, increased independence, and improved quality of life, supporting functional mobility and daily activity performance.
Product Description:
Dalfampridine extended-release (ER) tablets, marketed as Ampyra, are approved in the US by the FDA and in the EU via EMA for improving walking in multiple sclerosis (MS) patients. Regulatory approval requires a comprehensive dossier including clinical efficacy, safety data, manufacturing quality, and pharmacovigilance plans. In the US, the FDA reviews detailed clinical trial results and manufacturing standards, while the EMA ensures compliance with regional safety and quality standards.
Dalfampridine — third party manufacturing & bulk supply
Dalfampridine 10 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Indicative minimum order quantity
Dalfampridine is supplied as Extended-Release tablets (XR) — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Dalfampridine listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Dalfampridine →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Lamotriginevdispersible Tablets
Strength:
XR: 25 mg, 50 mg, 100 mg, 200 mg; IR: 25 mg, 100 mg, 200 mg, 300 mg
Form: Tablets(IR & ER)
Reference Brands: Lamictal, Lamictal XR(EU & US)
View Details
Tizanidine Tablets/Capsules
Strength:
2 mg and 4 mg
Form: Oral Capsules/Tablets
Reference Brands: Zanaflex (US)
View Details
Baclofen Tablets:
Strength:
10 mg and 20 mg
Form: Tablet
Reference Brands: Lioresal, Gablofen(US & EU)
View Details
Ofatumumab Injection
Strength:
20 mg/mL
Form: Injection(SQ)
Reference Brands: Kesimpta(US)
View DetailsQuick Response Guaranteed | Verified Suppliers
